BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ugarte-Gil MF, Mendoza-Pinto C, Reátegui-Sokolova C, Pons-Estel GJ, van Vollenhoven RF, Bertsias G, Alarcon GS, Pons-Estel BA. Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review. Lupus Sci Med 2021;8:e000542. [PMID: 34548375 DOI: 10.1136/lupus-2021-000542] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Parodis I. Molecular signature-based decision making in the era of targeted therapies for systemic lupus erythematosus. The Lancet Rheumatology 2022. [DOI: 10.1016/s2665-9913(22)00358-7] [Reference Citation Analysis]
2 Kandane-rathnayake R, Golder V, Louthrenoo W, Chen Y, Cho J, Lateef A, Hamijoyo L, Luo S, Wu YJ, Navarra SV, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake BMDB, Chan M, Kikuchi J, Takeuchi T, Bae S, Oon S, O'neill S, Goldblatt F, Ng KPL, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Yu D, Karyekar CS, Sing Lau C, Monk JA, Nikpour M, Hoi A, Morand EF. Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study. The Lancet Rheumatology 2022. [DOI: 10.1016/s2665-9913(22)00304-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhao Y, Smith D, Jorge A. Comparing two machine learning approaches in predicting lupus hospitalization using longitudinal data. Sci Rep 2022;12:16424. [PMID: 36180726 DOI: 10.1038/s41598-022-20845-w] [Reference Citation Analysis]
4 Shi Y, Bi D, Wang Y, Li R, Wu L, Zhao C, Wu Z, Duan X, Xu J, Zhan F, Yang M, Liu S, Li Q, Zhang S, Liu L, Zhao J, Tian X, Li X, Wang Q, Zeng X, CSTAR Co-authors. Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus. Front Med 2022;9. [DOI: 10.3389/fmed.2022.984183] [Reference Citation Analysis]
5 Zen M, Gatto M, Doria A. Defining the targets in SLE management: insights and unmet gaps. Ann Rheum Dis 2022:ard-2022-222991. [PMID: 36008131 DOI: 10.1136/ard-2022-222991] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ugarte-Gil MF, Hanly J, Urowitz M, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen DL, Askanase A, Pons-Estel BA, Alarcón GS. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Ann Rheum Dis 2022:annrheumdis-2022-222487. [PMID: 35944946 DOI: 10.1136/ard-2022-222487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 van Vollenhoven R, Askanase AD, Bomback AS, Bruce IN, Carroll A, Dall'Era M, Daniels M, Levy RA, Schwarting A, Quasny HA, Urowitz MB, Zhao MH, Furie R. Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria. Lupus Sci Med 2022;9:e000634. [PMID: 35346982 DOI: 10.1136/lupus-2021-000634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, Pimentel-Quiroz VR, Medina M, Elera-Fitzcarrald C, Zevallos F, Pastor-Asurza CA, Lofland J, Zazzetti F, Karyekar CS, Alarcón GS, Perich-Campos RA. LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort. Lupus Sci Med 2022;9:e000616. [PMID: 35193948 DOI: 10.1136/lupus-2021-000616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Perea-Seoane L, Agapito-Vera E, Gamboa-Cardenas RV, Guzmán-Sánchez G, Pimentel-Quiroz VR, Reategui-Sokolova C, Medina M, Elera-Fitzcarrald C, Noriega E, Rodriguez-Bellido Z, Pastor-Asurza C, Perich-Campos R, Alarcón GS, Ugarte-Gil MF. Relationship between care model and disease activity states and health-related quality of life in systemic lupus erythematosus patients. Lupus 2021;:9612033211063798. [PMID: 34969318 DOI: 10.1177/09612033211063798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]